Evonik Launches Sustainable Paper Bag for MetAMINO® Evonik Animal Nutrition has introduced a new, eco-friendly 25‑kg paper bag for its flagship product MetAMINO® (DL‑methionine), removing the traditional plastic film layer in favor of a fully recyclable paper construction. This move…
PPG and ArcelorMittal Advance Low-Carbon Automotive Manufacturing PPG and ArcelorMittal, a global leader in steel production, have unveiled a major milestone in their shared mission to reduce carbon emissions in the automotive manufacturing sector. The two industry giants are collaborating…
Alpha Cognition Reports Promising Preclinical Results for ALPHA-1062 in Military-Related Mild TBI Model Alpha Cognition Inc., a biopharmaceutical company focused on developing innovative treatments for neurodegenerative disorders, has announced encouraging preclinical data supporting the continued development of ALPHA-1062 for the…
Secures $2.15M NIH Grant to Advance AI-Driven Platform for CNS Drug Safety Prediction Quiver Bioscience, a discovery-stage biotechnology company focused on the treatment of serious central nervous system (CNS) disorders and chronic pain, has received a prestigious Phase II Small…
Market Outlook: Explosive Growth to 2030 The global oligonucleotide synthesis market is forecast to grow at a compound annual growth rate (CAGR) of 18.6%, reaching an estimated USD 24.7 billion by 2030, up from USD 10.5 billion in 2025. This dramatic increase reflects surging…
Merck KGaA, Darmstadt, Germany Finalizes $3.4 Billion Acquisition of SpringWorks Therapeutics Merck KGaA, Darmstadt, Germany, a global science and technology leader, has announced the completion of its acquisition of SpringWorks Therapeutics, Inc. for an enterprise value of $3.4 billion (approximately…
Vertex Secures EU Approval for ALYFTREK®, a New Once-Daily Treatment for Cystic Fibrosis Vertex Pharmaceuticals announced that the European Commission (EC) has approved ALYFTREK® (deutivacaftor/tezacaftor/vanzacaftor) for the treatment of cystic fibrosis (CF) in patients aged 6 years and older who…
Sensorion Reports Promising Early Data from Phase 1/2 Audiogene Gene Therapy Trial Sensorion (FR0012596468 – ALSEN), a clinical-stage biotechnology company focused on developing innovative therapies for hearing loss, has announced encouraging preliminary results from the first cohort of its Phase…
Chai Discovery Unveils Breakthrough With Chai-2: Fully De Novo Antibody Design Using AI Chai Discovery, a pioneer in AI-driven molecular design, has announced a major scientific breakthrough with the release of Chai-2, an advanced artificial intelligence model that achieves fully…
OS Therapies Reports Positive OST-HER2 Survival Data at Osteosarcoma Conference OS Therapies a clinical-stage biopharmaceutical company specializing in immunotherapy and Antibody Drug Conjugates (ADCs), has announced encouraging clinical data from its ongoing Phase 2b clinical trial of OST-HER2, a promising…
Syngenta to Lead Globally in Biological Farming Solutions As global agriculture faces the dual challenges of boosting productivity and ensuring sustainability, Syngenta is stepping up its game. The company is rapidly expanding its portfolio of nature-inspired, science-backed biological solutions. This…
EU Approves Eylea™ 8 mg for Extended 6-Month Dosing in nAMD and DME The European Commission (EC) has approved a label extension for Eylea™ 8 mg (aflibercept 8 mg, 114.3 mg/ml solution for injection), allowing extended treatment intervals of up…